Glenn P. Sblendorio
2012 - Medicines
In 2012, Glenn P. Sblendorio earned a total compensation of $2.8M as President and Chief Financial Officer at Medicines, a 44% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Non-Equity Incentive Plan | $480,344 |
| Option Awards | $630,891 |
| Salary | $547,500 |
| Stock Awards | $936,700 |
| Other | $71,005 |
| Total | $2,766,440 |
Sblendorio received $936.7K in stock awards, accounting for 34% of the total pay in 2012.
Sblendorio also received $100K in bonus, $480.3K in non-equity incentive plan, $630.9K in option awards, $547.5K in salary and $71K in other compensation.
Rankings
In 2012, Glenn P. Sblendorio's compensation ranked 2,536th out of 11,487 executives tracked by ExecPay. In other words, Sblendorio earned more than 77.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,536 out of 11,487 | 78th |
Division Manufacturing | 890 out of 4,253 | 79th |
Major group Chemicals And Allied Products | 203 out of 1,198 | 83rd |
Industry group Drugs | 120 out of 920 | 87th |
Industry Pharmaceutical Preparations | 97 out of 700 | 86th |
Source: SEC filing on April 30, 2015.
Sblendorio's colleagues
We found four more compensation records of executives who worked with Glenn P. Sblendorio at Medicines in 2012.